F. Radat and J. Swendsen, Psychiatric comorbidity in migraine: a review, Cephalalgia, vol.14, issue.30, pp.519-541, 2005.
DOI : 10.1016/0304-3959(90)91085-W

C. Lucas, M. Lantéri-minet, and L. Leroy, Comportements thérapeutiques des migraineux : à partir de FRAMIG 99, La lettre du neurologue, vol.IV, issue.5, pp.14-16, 2000.

C. Taimi, M. Navez, A. Perrin, and B. Laurent, Céphalées induites par abus des traitements symptomatiques antalgiques et antimigraineux, Rev. Neurol. (Paris), vol.157, pp.1221-1255, 2001.

J. Sénard, F. Nachit-ouinekh, J. Becq, G. Chastan, N. Fabre et al., Etude pharmaco??pid??miologique fran??aise de l???utilisation des triptans en m??decine g??n??rale, Th??rapie, vol.59, issue.5, pp.533-542, 2004.
DOI : 10.2515/therapie:2004091

M. Ferrari, K. Ronn, R. Lipton, and P. Goadsby, Oral triptans (serotonin 5-HT (1B/1D) agonists) in acute migraine treatment : a meta-analysis of 53 trials, Lancet. nov, vol.17358, issue.9294, pp.1668-75, 2001.

G. Mick and P. Baud, Crises migraineuses. Que savons-nous vraiment des triptans ?, Neurologies, vol.5, pp.468-72, 2002.

C. Creac-'h, Céphalées quotidiennes chroniques par abus de médicaments antalgiques : diagnostique et prise en charge thérapeutique, Medecine Therapeutique, vol.2009, issue.4, pp.169-80

C. Lucas, C. Chaffaut, M. Artaz, and M. Lantéri-minet, FRAMIG 2000: Medical and Therapeutic Management of Migraine in France, Cephalalgia, vol.21, issue.4, pp.267-79, 2005.
DOI : 10.1016/s0304-3959(02)00348-2

V. Dousset, P. Henry, and P. Michel, Epidémiologie des céphalées, Rev. Neurol.Tome, vol.156, pp.4-24, 2000.

M. Lantéri-minet, D. Valade, G. Géraud, M. Chautard, and C. Lucas, Migraine and Probable Migraine ??? Results of FRAMIG 3, a French Nationwide Survey Carried out According to the 2004 IHS Classification, Cephalalgia, vol.23, issue.12, pp.1146-58, 2005.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

M. Weber, J. Daurès, N. Fabre, P. Druais, J. Dardenne et al., Influence of general practitioners' personnel knowledge on migraine in medical attitudes towards their patients suffering from migraine, Rev. Neurol, vol.158, issue.4, pp.439-484, 2002.

P. Michel, P. Henry, L. Letenneur, M. Jogeix, A. Corson et al., Diagnostic screen for assessment of the IHS criteria for migraine by general practitionners, Cephalalgia, vol.13, pp.54-59, 1993.

. Lucas-c, M. Lantéri-minet, M. Chautard, . Framig, and . Iii, Prise en charge des patients migraineux: importance de la première consultation. Douleurs, pp.11-12, 2014.

T. Steiner, Diagnosis, prevalence estimation and burden measurement in population surveys of headache :presenting the HARDSHIP questionnaire. Headache and Pain, pp.10-1186, 2014.

M. Linet, An Epidemiologic Study of Headache Among Adolescents and Young Adults, JAMA: The Journal of the American Medical Association, vol.261, issue.15, p.2211, 1989.
DOI : 10.1001/jama.1989.03420150061038

X. Hu, Burden of Migraine in the United States, Archives of Internal Medicine, vol.159, issue.8, pp.813-821, 1999.
DOI : 10.1001/archinte.159.8.813

P. Michel, Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort, Cephalalgia, vol.19, issue.5, pp.503-513, 1999.
DOI : 10.1046/j.1468-2982.1999.019005503.x

C. Lucas, M. Lantéri-minet, and C. Chaffaut, Les relations médecins-migraineux. FRAMIG 2000-III, Douleurs, vol.2, pp.244-246, 2001.

M. Popier, Prise en charge de la migraine de l'adulte en médecine générale : Evaluation des pratiques thérapeutiques en aigu et en chronique à l'échelle régionale

R. Purdy, Conclusion:, The Canadian Journal of Neurological Sciences, vol.29, issue.S2, pp.3-7, 2002.
DOI : 10.1097/00001888-200104000-00021

D. Diego, E. Lantéri-minet, and M. , Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT)

M. Levin, Opioids in Headache, Headache: The Journal of Head and Face Pain, vol.104, issue.Suppl. 1, 2013.
DOI : 10.1111/head.12266

M. Lantéri-minet, Prevalence and description of chronic daily headache in the general population in France, Pain, vol.102, issue.1, pp.143-152, 2003.
DOI : 10.1016/s0304-3959(02)00348-2

C. Lucas, ??tat des lieux de l???utilisation des triptans en France, Douleurs : Evaluation - Diagnostic - Traitement, vol.5, issue.3, pp.5144-148, 2004.
DOI : 10.1016/S1624-5687(04)94507-6

C. Lucas, M. Lantéri-minet, and C. Chaffaut, Comportements thérapeutiques des migraineux. FRAMIG 2000-II, Douleurs, vol.2, pp.240-246, 2001.

C. Lucas, Dépression et migraine, p.141, 2012.

R. Silva-neto, K. Almeida, and S. Bernardino, Analysis of the duration of migraine prophylaxis, Journal of the Neurological Sciences, vol.337, issue.1-2
DOI : 10.1016/j.jns.2013.11.013